Background: In our companion article, we examined the role of MyD88-dependent signaling in ethanol (EtOH) consumption in mice lacking key components of this inflammatory pathway and observed differential effects on drinking. Here, we studied the role of these same signaling components in the acute sedative, intoxicating, and physiological effects of EtOH. Toll-like receptor 4 (TLR4) has been reported to strongly reduce the duration of EtOH-induced sedation, although most studies do not support its direct involvement in EtOH consumption. We examined TLR4 and other MyD88 pathway molecules to determine signaling specificity in acute EtOH-related behaviors. We also studied other GABAergic sedatives to gauge the EtOH specificity and potential role for GABA in EtOH's sedative and intoxicating effects in the mutant mice.
A LCOHOL CONSUMPTION IN animal models of excessive drinking and human alcoholics has been linked with increased innate immune signaling (Blednov et al., 2011; Crews and Vetreno, 2016) . Although deletion of certain immune-related genes reduces ethanol (EtOH) consumption (Mayfield et al., 2013 Robinson et al., 2014) , the specificity of EtOH's interaction with individual inflammatory mediators is not known. Most studies have focused on either the toxic, neurodegenerative effects of persistent activation of immune pathways by chronic EtOH, or the effects of inhibiting these pathways on EtOH consumption. Few studies have compared the effects of acute alcohol on other behaviors or physiological actions following manipulation of different immune signaling components.
Our companion paper (Blednov et al., 2017) provides novel evidence that deletion of specific components of the MyD88-dependent pathway can produce opposite actions on EtOH intake by decreasing (e.g., TLR2 or CD14 knockout [KO] ) or increasing (MyD88 KO) drinking. Deletion of TLR4 had no effect on drinking as previously reported in KO mice (Alfonso-Loeches et al., 2010; Pascual et al., 2011) . Based on these differential actions, we further examined the effects of these same signaling components on acute EtOH-related behaviors.
Previous studies showed that the duration of EtOHinduced loss of righting reflex (LORR) decreased in mice lacking TLR2, TLR4, or MyD88 (Corrigan et al., 2015; Harris et al., 2016; Wu et al., 2012) . We hypothesized that MyD88 pathway components are also involved in other behaviors and compared the effects of EtOH and other sedatives (gabadoxol, pentobarbital, and diazepam) on the duration of LORR and recovery from acute motor incoordination in mice lacking CD14, TLR2, TLR4, or MyD88. Considering the well-known actions of EtOH on GABAergic function and the evidence that acute EtOH potentiates GABAergic synaptic transmission via CD14/ TLR4 signaling in mouse neurons (Bajo et al., 2014) , other GABAergic sedatives were tested to determine the EtOH specificity and the role for GABA-mediated signaling in the sedative and intoxicating effects. In addition, we examined potential genotype differences in EtOH-induced hypothermia and blood EtOH clearance because these physiological factors can affect the behavioral phenotypes.
MATERIALS AND METHODS

Mice
Generation of Cd14 (B6.129S4-Cd14 /J, stock #009088) KO mice were described previously (Hou et al., 2008; Moore et al., 2000; Wooten et al., 2002) . The C57BL/10ScN mouse was used as a TLR4-deficient model (B6.B10ScN-Tlr4 lps-del /JthJ, stock #007227). This strain is homozygous for a deletion allele Tlr4 lps-del that causes spontaneous deletion of TLR4, resulting in absence of TLR4 mRNA and protein. All mutant strains were purchased from The Jackson Laboratory (Bar Harbor, ME) and were backcrossed on a C57BL/ 6J genetic background more than 6 generations, and thus, the C57BL/6J inbred strain is an appropriate control for these studies (https://www.jax.org/jax-mice-and-services/customer-support/tec hnical-support/breeding-and-husbandry-support/considerationsfor-choosing-controls). C57BL/6J mice were taken from a colony maintained at The University of Texas (UT) at Austin (original breeders were purchased from The Jackson Laboratory). Mice were group-housed 4 to 5 per cage based on genotype and sex. The humidity and temperature of the rooms were kept constant, and they were maintained a 12/12-hour light/dark cycle with lights on at 7 AM. Food and water were available ad libitum. Behavioral testing began when the mice were at least 2 months old, and mice were weighed every 4 to 6 days. All experiments were conducted in isolated behavioral testing rooms in the Animal Resource Center at UT Austin with a reversed light/dark cycle to avoid external distractions. Before beginning experiments, mice were moved to their experimental room and remained there for 1 to 2 weeks to adapt to the new light/dark cycle. All experiments were approved by the University's Institutional Animal Care and Use Committee.
Drugs
Injectable EtOH (Aaper Alcohol and Chemical, Shelbyville, KY) solutions were prepared in 0.9% saline (20%, v/v) . Gaboxadol (Sigma-Aldrich, St. Louis, MO), diazepam (Sigma-Aldrich), and pentobarbital (Sigma-Aldrich RBI, Natick, MA) were dissolved in 0.9% saline. All drugs were injected intraperitoneally (i.p.) at 0.01 ml/g of body weight.
Loss of Righting Reflex
Sensitivity to the depressant effects of EtOH (3.6 g/kg, i.p.), gaboxadol (55 mg/kg, i.p.), and pentobarbital (50 mg/kg, i.p.) was determined using the LORR (sleep time) assay in mice. These drug doses were based on previous studies (Blednov et al., 2013 Boehm et al., 2004) . When mice became ataxic, they were placed in the supine position in V-shaped plastic troughs until they were able to right themselves 3 times within 30 seconds. Sleep time was defined as the time from being placed in the supine position until they regained their righting reflex.
Rotarod
Mice were trained on a fixed speed rotarod (Economex; Columbus Instruments, Columbus, OH) at 5 rpm, and training was considered complete when mice were able to remain on the rotarod for 60 seconds. Every 15 minutes after injection of EtOH (2 g/kg, i.p.) or diazepam (5 mg/kg, i.p.), mice were placed back on the rotarod and latency to fall was measured until mice were able to remain on the rotarod for 60 seconds.
Hypothermia
Mice were separated into individually ventilated hypothermia chambers to acclimate for 60 min. Mice were then removed from the chambers to record baseline temperatures using a TH-5 Thermalert monitoring thermometer and glycerol-lubricated RET-3 rectal probe (Physitemp Instruments, Inc., Clifton, NJ) that was inserted for 5 seconds. Immediately following baseline recording, each mouse was injected with EtOH (3.6 g/kg, i.p.) and placed back in its chamber. Rectal temperatures were monitored over 5 hours with measurements taken every 30 min following EtOH injection.
Ethanol Clearance
Animals were injected with a single dose of EtOH (4 g/kg, i.p.), and blood samples were taken from the retro-orbital sinus 30, 60, 120, 180, and 240 min after injection. Samples (~20 ll) were collected in capillary tubes and centrifuged for 6 min at 3,1009g using a Haematospin 1400 centrifuge (Analox Instruments, London, UK). The plasma samples were stored at À20°C until blood ethanol concentrations (BECs) were determined in 5-ll aliquots using an AM1 Alcohol Analyzer (Analox Instruments). The machine was calibrated every 15 samples using an industry standard, and BECs were determined using commercially available reagents according to the manufacturer's instructions. Samples were averaged from duplicate runs and expressed as mg/dl.
Statistical Analysis
Data are reported as the mean AE SEM. The statistics software program GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) was used to perform 1-way or 2-way ANOVAs, Student's t-tests, and Bonferroni or Dunnett's post hoc analyses. Data from male and female mice were analyzed separately.
RESULTS
Loss of Righting Reflex
The duration of LORR was measured following the injection of EtOH, gaboxadol, or pentobarbital in mice lacking CD14, TLR2, TLR4, or MyD88 versus control mice. For EtOH (3.6 g/kg), there was a shorter duration of LORR in TLR4-and MyD88-deficient mice of both sexes (Fig. 1A,D) . All male and female mutant mice had shorter duration of LORR after injection of gaboxadol (55 mg/kg) (Fig. 1B,E) . Fig. 1 . Duration of LORR induced by sedative drugs in mice lacking CD14, TLR2, TLR4, or MyD88. Effect of EtOH (3.6 g/kg, i.p.) injection in male mice (A) C57BL/6J, n = 34; CD14 and TLR2 KO, n = 16; B6.B10ScN, n = 11; MyD88 KO, n = 6 and female mice (D) C57BL/6J, n = 26; CD14 KO, n = 13; TLR2 KO, n = 15; B6.B10ScN, n = 14; MyD88 KO, n = 5. Effect of gaboxadol (55 mg/kg) injection in male mice (B) C57BL/6J, n = 11; CD14 KO, n = 10, TLR2 KO, n = 12; B6.B10ScN, n = 11; MyD88 KO, n = 17 and female mice (E) C57BL/6J, n = 11; CD14 KO, n = 10; TLR2 KO, n = 11; B6.B10ScN, n = 16; MyD88 KO, n = 13. Effect of pentobarbital (50 mg/kg) injection in male mice (C) C57BL/6J, n = 11; CD14 KO, n = 9, TLR2 KO, n = 12; B6.B10ScN, n = 11; MyD88 KO, n = 15 and female mice (F) C57BL/6J, n = 13; CD14 KO, n = 11; TLR2 KO, n = 14; B6.B10ScN, n = 18; MyD88 KO, n = 15. Values represent mean AE SEM. Data were analyzed by 1-way ANOVA followed by Dunnett's post hoc tests for multiple comparisons (***p < 0.001 compared to control). EtOH, ethanol; LORR, loss of righting reflex.
Male and female mice lacking TLR4 had reduced duration of pentobarbital (50 mg/kg)-induced LORR, but no other genotype differences were found (Fig. 1C,F) .
Motor Incoordination
Acute administration of EtOH (2 g/kg) produced motor incoordination in all genotypes. No differences in the recovery from EtOH-induced motor impairment were found in CD14 KO and TLR2 KO male mice versus control mice ( Fig. 2A,B) , while TLR4 and MyD88 mutant males recovered faster than controls (Fig. 2C,D) . Similar to male mice, no differences in the recovery from EtOH-induced motor incoordination were found in CD14 KO and TLR2 KO female mice versus controls (Fig. 3A,B) , while TLR4 and MyD88 mutant females recovered from EtOH-induced motor impairment faster than control mice (Fig. 3C,D) .
Acute administration of diazepam (5 mg/kg) produced motor incoordination in all genotypes. CD14, TLR4, and MyD88 mutant male mice recovered faster than control mice (Fig. 4) . No differences in the recovery from diazepam-induced motor incoordination were found between male TLR2 KO and control mice (Fig. 4B ). Although male MyD88 KO mice recovered faster than controls ( Fig. 4D ), this may be due to the impaired ability of diazepam to initially induce motor incoordination in the KO mice (see 15-min time point). Female mice of all genotypes showed greater motor impairment after acute administration of diazepam. Similar to males, CD14 and MyD88 KO female mice recovered from diazepaminduced motor incoordination faster than control mice (Fig. 5A,D) . Although the recovery in female mice lacking TLR4 was not significantly different from control mice, there was a significant genotype 9 time interaction effect (Fig. 5C ). As observed in male mice, no differences in the recovery from diazepam-induced motor impairment were found between female TLR2 KO and control mice (Fig. 5B) . Fig. 2 . Recovery from ethanol (EtOH)-induced motor incoordination in male mice lacking CD14, TLR2, TLR4, or MyD88. Data represent time in seconds on the rotarod after injection of EtOH (2 g/kg, i.p.). The same group of control mice is represented in A-D (C57BL/6J mice, n = 14). (A) CD14 KO mice, n = 6, F(1, 18) = 0.04, p > 0.05, effect of genotype; F(9, 162) = 184, p < 0.001, effect of time; F(9, 162) = 0.3, p > 0.05, genotype 9 time interaction. (B) TLR2 KO mice, n = 6, F(1, 18) = 0.22, p > 0.05, effect of genotype; F(9, 162) = 168, p < 0.001, effect of time; F(9, 162) = 0.4, p > 0.05, genotype 9 time interaction. (C) B6.B10ScN mice, n = 10, F(1, 22) = 37.4, p < 0.001, effect of genotype; F(9, 198) = 206, p < 0.001, effect of time; F(9, 198) = 12.3, p < 0.001, genotype 9 time interaction. (D) MyD88 KO mice, n = 8, F(1, 20) = 52.2, p < 0.001, effect of genotype; F(9, 180) = 229, p < 0.001, effect of time; F(9, 180) = 17.6, p < 0.001, genotype 9 time interaction. Values represent mean AE SEM. Data were analyzed by repeatedmeasures 2-way ANOVA and Bonferroni post hoc tests (**p < 0.01, ***p < 0.001 compared to control).
Hypothermia
The acute hypothermic responses to EtOH (3.6 g/kg, injected at time 0) in male and female control and mutant mice are shown in Table 1 . Maximum reduction in body temperature occurred 60 to 120 min after injection of EtOH followed by a gradual recovery period over the next 5 to 6 hours. No genotype differences in EtOH-induced hypothermic responses were found in male and female mice lacking CD14, TLR2, or TLR4 compared to control mice. Male and female mice lacking MyD88 recovered from EtOH-induced hypothermia slightly faster than control mice, effect of genotype in males and females, respectively: F(1, 10) = 6.8 and F(1, 13) = 4.9, p < 0.05; 2-way ANOVA. This would not account for the reduced EtOH-induced sedation given that these mice regain righting reflex within 60 min, and no differences in hypothermia are observed during this time period. Also, the genotype effect in MyD88 KO female mice is likely due to initial differences in body temperature. For example, female mice lacking MyD88 or TLR2 had significantly increased core body temperature measured at time 0 compared to control mice (Table 1) . A similar trend was observed in female mice lacking TLR4, but the genotype effect was not significant. Comparison of body temperature (time 0) using Student's t-tests showed that all 3 mutant strains were different from female control mice (p < 0.05 for TLR4 mutant; p < 0.01 for TLR2 and MyD88 mutants). The last column of Table 1 depicts the slopes of the curves during recovery from EtOH-induced hypothermia (measured from 60 to 360 min) in control and mutant mice; however, 1-way ANOVA revealed no significant genotype effects on slope in male or female mice.
Ethanol Clearance
BECs were measured 30, 60, 120, 180, and 240 min after injection of EtOH (4 g/kg). There were no differences in the rates of clearance of blood EtOH in male and female control and mutant mice and no differences in the slopes (Fig. 6) . 
DISCUSSION
Our companion paper provides novel evidence that deletion of individual signaling components of the MyD88 pathway has selective effects on EtOH consumption (Blednov et al., 2017) . MyD88 signaling is also implicated in the acute sedative and intoxicating effects of EtOH as shown in the current study. However, different pathway mediators were involved in the different behaviors. Our previous study of the interleukin-1 receptor type 1 (IL-1R1) pathway provides additional support that another inflammatory pathway using the MyD88 adapter protein can regulate distinct EtOH-mediated behaviors (Blednov et al., 2015) . For example, EtOH consumption was not altered in IL-1R1 KO mice, but IL-1R1 signaling was involved in EtOH-induced sedation and motor incoordination as well as withdrawal severity (Blednov et al., 2015) . The EtOH-and benzodiazepine-induced LORR phenotypes in IL-1R1 KO mice were similar to those observed in the TLR4 and MyD88 mutant mice shown here, and both studies suggest that a GABAergic mechanism may contribute to the altered sedative effects in these mutant strains. Although different proinflammatory pathways culminate in a common endpoint of elevated levels of cytokines, we have shown that simply inhibiting various pathway components does not always yield the same phenotype. Some, but not all, components are important in EtOH behaviors, and deletion of individual mediators can produce distinct behavioral responses to EtOH. Notably, some pathway components were linked with EtOH drinking while others were involved in EtOH's acute sedative and intoxicating effects. The behavioral tests that we used would produce either acutely elevated blood alcohol levels following i.p. injection or lower levels of chronically elevated blood alcohol following voluntary drinking. The short-term versus long-term EtOH exposure times could determine the impact (if any) of neuroimmune/inflammatory responses or the particular pathways involved. These Fig. 4 . Recovery from diazepam-induced motor incoordination in male mice lacking CD14, TLR2, TLR4, or MyD88. Data represent time in seconds on the rotarod after injection of diazepam (5 mg/kg, i.p.). The same group of control mice is represented in A-D (C57BL/6J mice, n = 13). (A) CD14 KO mice, n = 12, F(1, 23) = 33, p < 0.001, effect of genotype; F(6, 138) = 206, p < 0.001, effect of time; F(6, 138) = 16.6, p < 0.001, genotype 9 time interaction. (B) TLR2 KO mice, n = 10, F(1, 21) = 2.2, p > 0.05, effect of genotype; F(6, 126) = 217, p < 0.001, effect of time; F(6, 126) = 2.3, p < 0.05, genotype 9 time interaction. (C) B6.B10ScN mice, n = 13, F(1, 24) = 17.6, p < 0.001, effect of genotype; F(6, 144) = 249, p < 0.001, effect of time; F (6, 144) = 8.3, p < 0.001, genotype 9 time interaction. (D) MyD88 KO mice, n = 9, F(1, 20) = 80.8, p < 0.001, effect of genotype; F(6, 120) = 71.4, p < 0.001, effect of time; F(6, 120) = 24, p < 0.001, genotype 9 time interaction. Values represent mean AE SEM. Data were analyzed by repeatedmeasures 2-way ANOVA and Bonferroni post hoc tests (***p < 0.001 compared to control).
pathway components may also regulate normal brain function independent of inflammatory signaling.
In the present study, we consistently found that male and female mice lacking TLR4 or MyD88 were less sensitive to EtOH's acute sedative and intoxicating effects, whereas CD14 KO and TLR2 KO male and female mice did not differ from control mice in these tests (Table 2 ). All mutants studied were less sensitive to the sedative effects of gaboxadol, while only TLR4 mutant mice were less sensitive to pentobarbital-induced sedation. Inhibition of TLR4-MyD88 signaling also increased recovery from the motor incoordination induced by diazepam (Table 2) . Our companion study showed that TLR4 did not regulate EtOH consumption in male or female mice and MyD88 had a complex sex-dependent role (Blednov et al., 2017 ), but the current study supports a strong involvement of these components in the acute depressant actions of EtOH and other GABAergic sedative drugs (e.g., gaboxadol, diazepam).
The overall effects of EtOH and diazepam in the mutants were similar ( Table 2 ), suggesting that altered GABAergic responses may be a common mechanism as discussed earlier for IL-1R1 KO mice (Blednov et al., 2015) . Electrophysiological studies showed that acute EtOH potentiates GABAergic transmission in mouse central amygdala neurons via CD14/TLR4 signaling (Bajo et al., 2014) , and also support a role for IL-1R in acute EtOH-induced facilitation of GABAergic synaptic currents (Bajo et al., 2015) . The electrophysiological evidence corroborates our previous and current behavioral data showing that MyD88-related components potentially regulate the acute and chronic effects of EtOH via GABAergic signaling. Interestingly, electrophysiological evidence also supports distinct signaling roles for proinflammatory/neuroimmune molecules in basal GABAergic transmission (Bajo et al., 2014 (Bajo et al., , 2015 . It is also possible that EtOH directly stimulates TLR4-MyD88 signaling as has been proposed for opioid-induced activation of TLR4 (Hutchinson et al., 2010 ). An alternative possibility is . The same group of control mice is represented in A-D (C57BL/6J mice, n = 11). (A) CD14 KO mice, n = 9, F(1, 18) = 5.7, p < 0.05, effect of genotype; F(7, 126) = 112, p < 0.001, effect of time; F(7, 126) = 3.0, p < 0.01, genotype 9 time interaction. (B) TLR2 KO mice, n = 10, F(1, 19) = 1.2, p > 0.05, effect of genotype; F(7, 133) = 134, p < 0.001, effect of time; F(7, 133) = 0.7, p > 0.05, genotype 9 time interaction. (C) B6.B10ScN mice, n = 10, F(1, 19) = 3.8, p > 0.05, effect of genotype; F(7, 133) = 154, p < 0.001, effect of time; F(7, 133) = 2.8, p < 0.05, genotype 9 time interaction. (D) MyD88 KO mice, n = 8, F(1, 17) = 9.8, p < 0.01, effect of genotype; F(7, 119) = 90.1, p < 0.001, effect of time; F(7, 119) = 4.1, p < 0.001, genotype 9 time interaction. Values represent mean AE SEM. Data were analyzed by repeated-measures 2-way ANOVA and Bonferroni post hoc tests (*p < 0.05, **p < 0.01, ***p < 0.001 compared to control).
that EtOH activates this pathway by releasing endogenous activators of TLR4 such as HMGB1 (Crews et al., 2013; Zou and Crews, 2014) .
Our results in male and female mice are consistent with previous studies showing that the EtOH-induced duration of LORR decreased in male TLR4 KO mice or mice treated with the selective TLR4 inhibitor, (AE)-naloxone (Corrigan et al., 2015; Wu et al., 2012) . Thus, 2 different genetic mouse models (TLR4 KO and B6.B10ScN mice), as well as pharmacological inhibition of TLR4 in mice, confirm that TLR4 is involved in the acute sedative effects of EtOH; and we provide further evidence that male and female mice do not differ in the acute sedative or intoxicating effects. Different genetic and pharmacological mouse models have also provided corroborating evidence that TLR4 is not a critical determinant of EtOH drinking (Alfonso-Loeches et al., 2010; Bajo et al., 2016; Blednov et al., 2017; Pascual et al., 2011) , and we confirmed these findings in female mice. These results are further supported by an extensive body of research in male and female rats and mice, showing that genetic or pharmacologic manipulation of TLR4 does not regulate EtOH drinking, but the Data represent the mean body temperature AE SEM (°C) before (time 0) and after injection of EtOH (3.6 g/kg, i.p.), measured every 30 min over 360 min. Data were analyzed by 2-way ANOVA. There was a significant effect of genotype in male and female MyD88 KO mice (p < 0.05) and significant genotype 9 time interaction effects in female TLR2, TLR4, and MyD88 mutant mice (p < 0.001). Post hoc comparisons are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001 compared to the control (C57BL/6J) time point of the corresponding sex. Data in the last column represent the mean slope (expressed as 1/slope) of the curves AE SEM during recovery from EtOH-induced hypothermia (from 60 to 360 min); 1-way ANOVA revealed no significant genotype effects on slope in male or female mice. Fig. 6 . Clearance of blood ethanol (EtOH) in mice lacking CD14, TLR2, TLR4, or MyD88. Data represent the BEC over 4 hours in (A) male and (B) female mice after injection of EtOH (4 g/kg, i.p.). Control C57BL/6J mice (n = 8 males; n = 14 females); CD14 KO (n = 4 males; n = 9 females); TLR2 KO (n = 4 males; n = 9 females); B6.B10ScN (n = 11 males and females); and MyD88 KO mice (n = 7 females). Values represent mean AE SEM. Data were analyzed by 1-way ANOVA. BEC, blood EtOH concentration.
acute sedative effect of EtOH is decreased in TLR4 KO rats . Including our work in male and female B6.B10ScN mice, a role for TLR4 in EtOH's acute sedative effects (but not drinking) has now been validated in several different male and female rodent models. Although null mutations may induce compensatory molecular changes in the periphery and/or the central nervous system, our findings have been validated by studies using pharmacological inhibitors of TLR4 (described above). Previous TLR4 studies did not compare EtOH with other sedatives, but we now show that TLR4 is also involved in the sedative effects of GABAergic drugs such as gaboxadol and pentobarbital and does not specifically mediate EtOHinduced sedation.
In addition to TLR4, we demonstrate a key role for MyD88 in the sedative and intoxicating effects of EtOH in male and female mice, which is consistent with the findings reported by Wu and colleagues (2012) in male MyD88 KO mice. Our work further implicates TLR4-MyD88 signaling in the motor incoordination effects of diazepam and suggests that this pathway mediates the acute depressant effects of EtOH and other GABAergic sedatives in mice of both sexes.
Our results do not support a role for TLR2 in EtOHinduced sedation in contrast to the study by Corrigan and colleagues (2015) , which showed that LORR was almost completely eliminated in TLR2 KO mice. It should be noted that the TLR2 KO mice used in these studies were generated by different groups using different genetic backgrounds (Corrigan et al., 2015; Wooten et al., 2002) and may differ in developmental and compensatory changes associated with genetic deletion. Corrigan and colleagues (2015) used TLR2 KO mice on a Balb/c background, whereas the TLR2 KO mice used in our study were on a C57BL/6J background. However, the TLR4 KO and MyD88 KO mice studied in Wu and colleagues (2012) were on a Balb/c background and we observed similar LORR effects using mice on a C57BL/6J background. Although we found that TLR2 was not involved in the sedative response to EtOH, it was involved in gaboxadol-induced sedation (as were the other immune mediators that we studied). In contrast to the differential effects on voluntary EtOH consumption, the acute sedative and intoxicating effects of EtOH (or other GABAergic drugs) were regulated in a similar manner by several MyD88 pathway components, suggesting a role for overall cytokine signaling in these behaviors.
We studied EtOH-induced hypothermia and blood EtOH clearance because these physiological and pharmacokinetic effects can potentially impact the behaviors that we measured. Hypothermia can prolong EtOH's sedative effects, so we measured body temperature following the same dose of EtOH that was used in the LORR experiments. The rate of clearance of blood EtOH can also affect recovery from its sedative and intoxicating effects. However, there were no genotype differences in clearance or hypothermia that could account for the behavioral effects. Thus, the EtOH-induced behaviors measured in our 2 studies were not likely influenced by physiological or pharmacokinetic processes.
Collectively, our studies show that key mediators of the MyD88 inflammatory pathway are associated with distinct behavioral effects of EtOH. In general, TLR4 and MyD88 are implicated in the acute sedative and intoxicating effects of EtOH, while TLR2 and CD14 are implicated in EtOH drinking (although the effects of MyD88 effects are more complex as it may regulate drinking in male mice). Effects on EtOH consumption in some mutants depended on the sex of the mice (Blednov et al., 2017) , but sex was not an important factor for the effects of mutations on the sedative and intoxicating effects of EtOH. Although the involvement of neuroimmune signaling in the different behaviors is unknown, it appears that GABAergic regulation is important in EtOH's acute actions. Our studies provide novel evidence that individual players in the MyD88 pathway are associated with distinct EtOH-related behaviors, suggesting that signaling components can be selectively targeted to mitigate the effects of EtOH or other sedative drugs.
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